Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Immunity
|
March 19, 2020
Structural Analysis Reveals that the Cytokine IL-17F Forms a Homodimeric Complex with Receptor IL-17RC to Drive IL-17RA-Independent Signaling
Arnaud Goepfert, Sylvie Lehmann, Jutta Blank, et al.
Journal of Biomolecular Screening
|
June 9, 2006
Readout technologies for highly miniaturized kinase assays applicable to high-throughput screening in a 1536-well format
Martin Klumpp, Andreas Boettcher, Damaris Becker, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications
|
March 3, 2006
Purification, crystallization and preliminary crystallographic analysis of Arabidopsis thaliana imidazoleglycerol-phosphate dehydratase
Steven E Glynn, Patrick J Baker, Svetlana E Sedelnikova, et al.
Journal of Molecular Biology
|
February 28, 2012
Structural determinants of MALT1 protease activity
Christian Wiesmann, Lukas Leder, Jutta Blank, et al.
Chemmedchem
|
February 9, 2024
Challenges for the Discovery of Non-Covalent WRN Helicase Inhibitors
Alisa Heuser, Wassim Abdul Rahman, Elisabeth Bechter, et al.
Medchemcomm
|
August 16, 2018
Approaches to selective fibroblast growth factor receptor 4 inhibition through targeting the ATP-pocket middle-hinge region
Robin A Fairhurst, Thomas Knoepfel, Catherine Leblanc, et al.
Journal of Medicinal Chemistry
|
January 21, 2012
[1,2,4]triazol-3-ylsulfanylmethyl)-3-phenyl-[1,2,4]oxadiazoles: antagonists of the Wnt pathway that inhibit tankyrases 1 and 2 via novel adenosine pocket binding
Michael D Shultz, Christina A Kirby, Travis Stams, et al.
Chembiochem : a European Journal of Chemical Biology
|
October 17, 2015
Gift from Nature: Cyclomarin A Kills Mycobacteria and Malaria Parasites by Distinct Modes of Action
Nathalie Bürstner, Silvio Roggo, Nils Ostermann, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 16, 2018
N-aryl-piperidine-4-carboxamides as a novel class of potent inhibitors of MALT1 proteolytic activity
Achim Schlapbach, Laszlo Revesz, Carole Pissot Soldermann, et al.
Cancer Research
|
June 24, 2011
A drug resistance screen using a selective MET inhibitor reveals a spectrum of mutations that partially overlap with activating mutations found in cancer patients
Ralph Tiedt, Elisa Degenkolbe, Pascal Furet, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Immunity
|
March 19, 2020
Structural Analysis Reveals that the Cytokine IL-17F Forms a Homodimeric Complex with Receptor IL-17RC to Drive IL-17RA-Independent Signaling
Arnaud Goepfert, Sylvie Lehmann, Jutta Blank, et al.
Journal of Biomolecular Screening
|
June 9, 2006
Readout technologies for highly miniaturized kinase assays applicable to high-throughput screening in a 1536-well format
Martin Klumpp, Andreas Boettcher, Damaris Becker, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications
|
March 3, 2006
Purification, crystallization and preliminary crystallographic analysis of Arabidopsis thaliana imidazoleglycerol-phosphate dehydratase
Steven E Glynn, Patrick J Baker, Svetlana E Sedelnikova, et al.
Journal of Molecular Biology
|
February 28, 2012
Structural determinants of MALT1 protease activity
Christian Wiesmann, Lukas Leder, Jutta Blank, et al.
Chemmedchem
|
February 9, 2024
Challenges for the Discovery of Non-Covalent WRN Helicase Inhibitors
Alisa Heuser, Wassim Abdul Rahman, Elisabeth Bechter, et al.
Medchemcomm
|
August 16, 2018
Approaches to selective fibroblast growth factor receptor 4 inhibition through targeting the ATP-pocket middle-hinge region
Robin A Fairhurst, Thomas Knoepfel, Catherine Leblanc, et al.
Journal of Medicinal Chemistry
|
January 21, 2012
[1,2,4]triazol-3-ylsulfanylmethyl)-3-phenyl-[1,2,4]oxadiazoles: antagonists of the Wnt pathway that inhibit tankyrases 1 and 2 via novel adenosine pocket binding
Michael D Shultz, Christina A Kirby, Travis Stams, et al.
Chembiochem : a European Journal of Chemical Biology
|
October 17, 2015
Gift from Nature: Cyclomarin A Kills Mycobacteria and Malaria Parasites by Distinct Modes of Action
Nathalie Bürstner, Silvio Roggo, Nils Ostermann, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 16, 2018
N-aryl-piperidine-4-carboxamides as a novel class of potent inhibitors of MALT1 proteolytic activity
Achim Schlapbach, Laszlo Revesz, Carole Pissot Soldermann, et al.
Cancer Research
|
June 24, 2011
A drug resistance screen using a selective MET inhibitor reveals a spectrum of mutations that partially overlap with activating mutations found in cancer patients
Ralph Tiedt, Elisa Degenkolbe, Pascal Furet, et al.
Page
of 3